HOG
29
-4
HIG
67
4
BBY
40
3
NWL
44
-4
DTE
50
3
NWSA
62
2
UPS
41
-4
MRO
55
3
HSIC
54
-3
MA
55
-7
XYL
37
2
F
43
-8
PDCO
35
-3
NTAP
64
2
COP
56
2
WDC
41
-2
HCP
58
4
C
58
-2
MDLZ
34
2
CVS
48
3
HOG
29
-4
HIG
67
4
BBY
40
3
NWL
44
-4
DTE
50
3
NWSA
62
2
UPS
41
-4
MRO
55
3
HSIC
54
-3
MA
55
-7
XYL
37
2
F
43
-8
PDCO
35
-3
NTAP
64
2
COP
56
2
WDC
41
-2
HCP
58
4
C
58
-2
MDLZ
34
2
CVS
48
3
Financhill
Back

CRISPR Therapeutics AG Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

CRSP
CRISPR Therapeutics AG

Last Price:
46.26
Seasonality Move:
12.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

CRISPR Therapeutics AG Price Quote

$46.26
-1.00 (-2.12%)
(Updated: November 21, 2024 at 2:50 PM ET)

CRISPR Therapeutics AG Key Stats

Sell
44
CRISPR Therapeutics AG (CRSP) is a Sell
Day range:
$46.61 - $47.91
52-week range:
$43.42 - $91.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.08%
Volume:
1.9M
Avg. volume:
1.6M
1-year change:
-34.52%
Market cap:
$4B
Revenue:
$370M
EPS:
$-2.8

How Much Does CRISPR Therapeutics AG Make?

Data Unavailable

Is CRISPR Therapeutics AG Growing As A Company?

Data Unavailable

CRISPR Therapeutics AG Stock Price Performance

What Is CRISPR Therapeutics AG 52-Week High & Low?

CRISPR Therapeutics AG Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CRISPR Therapeutics AG?

Is CRISPR Therapeutics AG Cash Flow Positive?

  • What Is CRSP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$188.8M
  • What Is CRISPR Therapeutics AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $354M
  • What Is CRISPR Therapeutics AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$467.8M

CRISPR Therapeutics AG Return On Invested Capital

Data Unavailable

CRISPR Therapeutics AG Earnings Date & Stock Price

CRISPR Therapeutics AG Competitors

CRISPR Therapeutics AG Dividend Yield

CRISPR Therapeutics AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 28.11%
Revenue: 0% -91.56%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 11
Sell Recommendations: 2
Price Target: 81.54
Upside from Last Price: 72.54%

Major Shareholders

  • How many CRSP shares are owned by institutional investors?
    98.8M CRSP shares are owned by institutional investors
  • How many CRSP shares are owned by insiders?
    1.6M CRSP shares are owned by insiders